FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -19.56 32.69 -40.64
Graham Fair Price -41.19 280775.48 477463.96
PEG -1616.91 -0.17 < 0.005
Price/Book -4.63 0.97 1.02
Price/Cash Flow 36.74 90.18 65.95
Prices/Earnings 187.26 10.96 3.81
Price/Sales 37.80 6.07 4.40
Price/FCF 36.74 90.18 65.95
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -69.10 0.20 0.65
Operating Margin 20.56 0.18 -0.15
ROA -66.20 0.01 0.04
ROE 0.07 0.02 -66.80
ROIC -0.02 0.02 -14.30
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.04 0.03 53.78
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.77 1.85 141.07
EPS QOQ 3.95 -0.66 -83.27
FCF QOQ 0.04 -0.29 643.72
Revenue QOQ 1.05 -0.30 -71.94
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 47.60 29.05 -38.98
Days Sales Outstanding (DSO) 30.56 51.83 69.63
Inventory Turnover 1.89 3.10 63.89
Debt/Capitalization 0.19 0.18 -4.95
Quick Ratio 39.71 1.61 -95.95
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 389038.61 397041.76 2.06
Cash 116198.04 131302.58 13.00
Capex -3956.42 -3052.03 22.86
Free Cash Flow 6024.74 4288.68 -28.82
Revenue 90239.40 63739.69 -29.37
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 39.71 1.77 -95.54
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -5.53 4.43 -19.91
Naive Interpretation Member
06 - Financial Health · Weak
Rating